oAlert.pl
WARNING: RECALLED PRODUCT
PL EN

RANIGAST

The risk may be caused by the potential presence of N-nitrosodimethylamine (NDMA) contamination in the medicinal product, which may affect human health and life. Potential effects: possible carcinogenic and other toxic effects, risk to health and life.

Download the app and stay informed

Get instant notifications about recalled products and protect your family.

RANIGAST
Risk Level
Critical
Manufacturer
Zakłady Farmaceutyczne POLPHARMA S.A.
Batch Number
wszystkie serie
Recall Date
19.09.2019
View official statement

Important Information

What You Should Know

Recommendations

Do not use the product from any batch. Patients who have this medicine should stop using it, return the packs to a pharmacy, and consult a doctor to choose alternative treatment.

Actions Taken

Suspension of distribution throughout the country of all batches of the medicinal product Ranigast (Ranifidinum) 150 mg, film-coated tablets, and granting the decision immediate enforceability.

Need Help?

If you feel unwell after consuming this product, contact your doctor or call the poison control center.

FAQ

Frequently Asked Questions

Is this product safe to consume?
No. This product has been recalled due to: The risk may be caused by the potential presence of N-nitrosodimethylamine (NDMA) contamination in the medicinal product, which may affect human health and life. Potential effects: possible carcinogenic and other toxic effects, risk to health and life.
What should I do if I already bought this?
Stop using the product immediately. Return it to the store for a full refund. If you consumed it and feel unwell, contact your doctor.
Which batches are affected?
Affected batch numbers: wszystkie serie

Related

Other Recalled Products